| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advance in the pharmacological and comorbidities management of heart failure with preserved ejection fraction: evidence from clinical trials
|
Meifang, Wu
|
|
|
29 |
2 |
p. 305-320
|
artikel
|
| 2 |
Anti-bradycardia pacing—impact on patients with HFpEF: a systematic review
|
Ababei, Alexandru
|
|
|
29 |
2 |
p. 523-534
|
artikel
|
| 3 |
Assessment and management of heart failure in patients with chronic kidney disease
|
Guaricci, Andrea Igoren
|
|
|
29 |
2 |
p. 379-394
|
artikel
|
| 4 |
A systematic review and meta-analysis of the efficacy and safety of Mavacamten therapy in international cohort of 524 patients with hypertrophic cardiomyopathy
|
Yacoub, Magdi S.
|
|
|
29 |
2 |
p. 479-496
|
artikel
|
| 5 |
Can the hemodynamic model in heart failure be restored based on analysis of ventricular-arterial coupling?
|
Soma, Johannes
|
|
|
29 |
2 |
p. 463-464
|
artikel
|
| 6 |
Clinical staging of Anderson-Fabry cardiomyopathy: An operative proposal
|
Del Franco, Annamaria
|
|
|
29 |
2 |
p. 431-444
|
artikel
|
| 7 |
Correction to: Clinical staging of Anderson‑Fabry cardiomyopathy: an operative proposal
|
Del Franco, Annamaria
|
|
|
29 |
2 |
p. 571
|
artikel
|
| 8 |
Current perspectives of sudden cardiac death management in hypertrophic cardiomyopathy
|
Pu, Lutong
|
|
|
29 |
2 |
p. 395-404
|
artikel
|
| 9 |
Device therapy for patients with atrial fibrillation and heart failure with preserved ejection fraction
|
Zhang, Zixi
|
|
|
29 |
2 |
p. 417-430
|
artikel
|
| 10 |
Echocardiographic manifestations in end-stage renal disease
|
Ito, Takahide
|
|
|
29 |
2 |
p. 465-478
|
artikel
|
| 11 |
Investigating the place of sodium-glucose cotransporter-2 inhibitors and dual sodium-glucose cotransporter-1 and dual sodium-glucose cotransporter-2 inhibitors in heart failure therapy: a systematic review of the literature
|
McKenzie, Taylor
|
|
|
29 |
2 |
p. 549-558
|
artikel
|
| 12 |
Molecular mechanisms and emerging therapies in wild-type transthyretin amyloid cardiomyopathy
|
Wu, Danni
|
|
|
29 |
2 |
p. 511-521
|
artikel
|
| 13 |
Multidisciplinary approach in cardiomyopathies: From genetics to advanced imaging
|
Santoro, Francesco
|
|
|
29 |
2 |
p. 445-462
|
artikel
|
| 14 |
Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy
|
Dini, Frank L.
|
|
|
29 |
2 |
p. 367-378
|
artikel
|
| 15 |
Predictive biomarkers for the early detection and management of heart failure
|
Mariappan, Vignesh
|
|
|
29 |
2 |
p. 331-353
|
artikel
|
| 16 |
Right ventricular dysfunction in left ventricular assist device candidates: is it time to change our prospective?
|
Sciaccaluga, Carlotta
|
|
|
29 |
2 |
p. 559-569
|
artikel
|
| 17 |
Sex differences in transthyretin cardiac amyloidosis
|
Aimo, Alberto
|
|
|
29 |
2 |
p. 321-330
|
artikel
|
| 18 |
Takotsubo pathophysiology and complications: what we know and what we do not know
|
Shadmand, Mehdi
|
|
|
29 |
2 |
p. 497-510
|
artikel
|
| 19 |
The prevalence of coronary microvascular dysfunction (CMD) in heart failure with preserved ejection fraction (HFpEF): a systematic review and meta-analysis
|
Lin, Xiaoxiao
|
|
|
29 |
2 |
p. 405-416
|
artikel
|
| 20 |
The role and application of current pharmacological management in patients with advanced heart failure
|
Palazzuoli, Alberto
|
|
|
29 |
2 |
p. 535-548
|
artikel
|
| 21 |
The sympathetic nervous system in heart failure revisited
|
Triposkiadis, Filippos
|
|
|
29 |
2 |
p. 355-365
|
artikel
|
Tijdschrift beschrijving